Abstract:Renal cell carcinoma (RCC) is a common malignancy of the urinary system. Although traditional therapies, such as surgery assisted with chemotherapy have improved the quality of life and survival time of patients with RCC, patients with metastasis or recurrence benefit little from such therapies. At present, little is known about the underlying mechanisms of RCC, rendering treatment selection and implementation challenging. Therefore, investigating the cause and underlying mechanisms of RCC remain of importance to explore potential new avenues for its treatment. Inter-alpha-trypsin inhibitor heavy chain 1 (ITIH1) is an inflammation-associated gene reported to suppress the progression of liver cancer. However, its role in RCC remains poorly understood. Therefore, the present study aimed to investigate the role and mechanism of ITIH1 in RCC. Based on data obtained from The Cancer Genome Atlas database, ITIH1 expression was demonstrated to be significantly higher in tumor tissues compared with normal tissues, which was in turn negatively associated with the survival of patients with RCC. However, in RCC cells, ITIH1 was shown to be expressed at significantly lower levels compared with those in HK-2 cells. The discrepancy between tissues and cell lines might be due to the different environment of cell growth. ITIH1 knockdown in RCC cells significantly increased cell proliferation and invasion whilst significantly decreasing the apoptosis rate, compared with those in control cells (without ITIH1 knockdown). By contrast, overexpression of ITIH1 significantly inhibited cell proliferation and invasion in RCC cells. In terms of western blotting results, the phosphorylation levels of NF-kappa B were significantly increased following ITIH1 knockdown. The protein expression level of I kappa B significantly decreased whereas that of IKK, Cyclin D1, proliferating cell nuclear antigen and alpha-smooth muscle actin were significantly increased in ITIH1-knockdown cells, compared with those in the control cells (without ITIH1 knockdown). This suggests that the NF-kappa B pathway may be activated after ITIH1 knockdown. Following treatment with the NF-kappa B pathway inhibitor JSH-23 in combination with ITIH1 knockdown, RCC cell proliferation and invasion were significantly reduced compared with those after ITIH1 knockdown alone. In summary, results from the present study suggest that ITIH1 can serve an inhibitory role in the progression of RCC, which could potentially be inhibited through the NF-kappa B signaling pathway.

Hint1 Up-Regulates IκBα by Targeting the β-TrCP Subunit of SCF E3 Ligase in Human Hepatocellular Carcinoma Cells

Hint1 suppresses migration and invasion of hepatocellular carcinoma cells in vitro by modulating girdin activity

STAT1 Inhibits Human Hepatocellular Carcinoma Cell Growth Through Induction of P53 and Fbxw7

Hint1 (Histidine Triad Nucleotide-Binding Protein 1) Attenuates Cardiac Hypertrophy Via Suppressing Hoxa5 (Homeobox A5) Expression

Advances on HINT1, a Novel Tumor Suppressor

Clinical significance of down-regulated HINT2 in hepatocellular carcinoma.

HINT2 Downregulation Promotes Colorectal Carcinoma Migration and Metastasis.

HINT2 Triggers Mitochondrial Ca2+ Influx by Regulating the Mitochondrial Ca2+ Uniporter (MCU) Complex and Enhances Gemcitabine Apoptotic Effect in Pancreatic Cancer

Hint1 Expression Inhibits Proliferation and Promotes Radiosensitivity of Human SGC7901 Gastric Cancer Cells.

Histidine Triad Nucleotide Binding Protein 1 Attenuates Cardiac Hypertrophy via Suppressing Homeobox A5 Expression

ITIH1 Suppresses Carcinogenesis in Renal Cell Carcinoma Through Regulation of the NF‑κB Signaling Pathway

STAT3-Mediated Promoter-Enhancer Interaction Up-Regulates Inhibitor of DNA Binding 1 (ID1) to Promote Colon Cancer Progression

[Histidine Triad Nucleotide-Binding Protein 1 and Human Diseases].

Human Inhibitor of Growth 1 Inhibits Hepatoma Cell Growth and Influences P53 Stability in a Variant-Dependent Manner.

HINT1 in Neuropsychiatric Diseases: A Potential Neuroplastic Mediator.

Silencing of KNTC1 Inhibits Hepatocellular Carcinoma Cells Progression Via Suppressing PI3K/Akt Pathway

HINT2 protects against pressure overload‐induced cardiac remodelling through mitochondrial pathways

Notch1 Signaling Sensitizes Tumor Necrosis Factor-related Apoptosis-inducing Ligand-induced Apoptosis in Human Hepatocellular Carcinoma Cells by Inhibiting Akt/Hdm2-mediated P53 Degradation and Up-regulating P53-Dependent DR5 Expression*

Post-translational modification of HINT1 mediates activation of MITF transcriptional activity in human melanoma cells

ICBP90 Mediates Notch Signaling to Facilitate Human Hepatocellular Carcinoma Growth.

Clinical Significance of Expression of Hint1 and Potential Epigenetic Mechanism in Gastric Cancer.